These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8438282)

  • 1. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant.
    Cocanougher B; Ballantyne CM; Pollack MS; Payton-Ross C; Lowry R; Kleiman NS; Farmer JA; Noon GP; Short HD; Young JB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):233-6. PubMed ID: 8438282
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility.
    Costanzo-Nordin MR
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S90-103. PubMed ID: 1623009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation.
    Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M
    Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation.
    Pfeffer PF; Foerster A; Frøysaker T; Thorsby E
    Transplant Proc; 1987 Feb; 19(1 Pt 1):691-2. PubMed ID: 3274844
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection.
    Gonzalez-Stawinski GV; Cook DJ; Chui J; Gupta S; Navia JL; Hoercher K; Taylor DO; Yamani MH; Starling RC; Smedira NG
    J Surg Res; 2007 Oct; 142(2):233-8. PubMed ID: 17727888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation.
    Daly RC; Topilsky Y; Joyce L; Hasin T; Gandhi M; Rosen C; Heimbach J; Edwards BS; Pereira N; Stulak JM; Arendt CJ; Park SJ; Kushwaha SS
    Transplantation; 2013 Jan; 95(2):e2-4. PubMed ID: 23325010
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA antigen mismatching and HLA-specific antibodies in heart transplantation: review of a single center experience. The Manchester Wythenshawe Heart Transplant Team.
    Sheldon S; Dyer PA
    Transplant Proc; 1992 Dec; 24(6):2438. PubMed ID: 1465821
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy.
    Rose ML
    J Heart Lung Transplant; 1996 Apr; 15(4):342-9. PubMed ID: 8732592
    [No Abstract]   [Full Text] [Related]  

  • 17. New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes.
    Shahzad K; Aziz QA; Leva JP; Cadeiras M; Ho EK; Vlad G; Vasilescu ER; Latif F; Sinha A; Burke E; Addonizio LJ; Restaino SW; Marboe CC; Suciu-Foca N; Naka Y; Mancini D; Deng MC
    J Heart Lung Transplant; 2011 Feb; 30(2):194-203. PubMed ID: 20952209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol of alpha and beta lipoproteins in ischemic heart disease.
    Alvarado M; Méndez D; Rivera-Hidalgo PR
    Arch Invest Med (Mex); 1981; 12(4):589-98. PubMed ID: 7332395
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
    Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
    Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.